Skip to main content

Advertisement

SpringerLink
Log in

Nutritional treatments in inflammatory bowel disease

  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Opinion statement

  • The role of nutritional intervention in inflammatory bowel disease (IBD) is twofold: first, as primary therapy for patients with acute Crohn’s disease; second, as an invaluable adjunctive therapy for the correction and maintenance of nutritional status for both patients with Crohn’s disease and those with ulcerative colitis. Careful nutritional monitoring and appropriate nutritional intervention throughout all stages of disease should be an integral part of the multidisciplinary management approach to IBD.

  • In terms of primary therapy, polymeric and elemental enteral diets are an effective therapy for patients with acute Crohn’s disease, offering an unrivaled safety profile and significant nutritional benefits. Enteral diets should be considered as primary therapy in children with Crohn’s disease, especially in those with poor nutritional status or growth impairment, and in patients with severe drug-induced side effects. Total parenteral nutrition (TPN) does not have a primary therapeutic role in patients with IBD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Greenberg GR, Fleming CR, Jeejeebhoy KN, et al.: Controlled trial of bowel rest and nutritional support in the management of Crohn’s disease. Gut 1988, 29:1309–1315.

    PubMed  CAS  Google Scholar 

  2. O’Morain C, Segal AW, Levi AJ: Elemental diet as primary treatment of acute Crohn’s disease: a controlled trial. Br Med J 1984, 288:1859–1862.

    Article  CAS  Google Scholar 

  3. Fernandez-Banares F, Cabre E, Esteve-Comas M, Gassull MA: How effective is enteral nutrition in inducing clinical remission in active Crohn’s disease? A meta-analysis of the randomized clinical trials. JPEN J Parenter Enteral Nutr 1995, 19:356–364.

    Article  PubMed  CAS  Google Scholar 

  4. Messori A, Trallori G, D’Albasio G, et al.: Definedformula diets versus steroids in the treatment of active Crohn’s disease: a meta-analysis. Scand J Gastroenterol 1996, 31:267–272.

    PubMed  CAS  Google Scholar 

  5. Teahon K, Bjarnason I, Pearson M, Levi AJ: Ten years’ experience with an elemental diet in the management of Crohn’s disease. Gut 1990, 31:1133–1137.

    PubMed  CAS  Google Scholar 

  6. Fell JM, Paintin M, Arnaud-Battandier F, et al.: Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn’s disease. Aliment Pharm Ther 2000, 14:281–289. This article presents evidence that enteral diet therapy down-regulates mucosal inflammatory cytokines.

    Article  CAS  Google Scholar 

  7. O’Sullivan M, O’Morain C: Nutritional therapy in Crohn’s disease. Inflamm Bowel Dis 1998, 4:45–53.

    Article  PubMed  CAS  Google Scholar 

  8. Lomer M, Harvey R, Evans S, et al.: Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn’s disease. Eur J Gastroenterol Hepatol 2001, 13:101–106. Outlines a novel theory and data that may in part explain the therapeutic effect of an elemental diet.

    Article  PubMed  CAS  Google Scholar 

  9. Powell JJ, Ainley CC, Harvey RS, et al.: Characterisation of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut 1996, 38:390–395.

    PubMed  CAS  Google Scholar 

  10. Winter TA, Lemmer ER, O’Keefe S, Ogden JM: The effect of severe undernutrition, and subsequent refeeding on digestive function in human patients. Eur J Gastroenterol Hepatol 2000, 12:191–196. Highlights and describes key adverse consequences of undernutrition on the gastrointestinal tract.

    PubMed  CAS  Google Scholar 

  11. Geerling BJ, Badart-Smook A, Stockbrugger RW, Brummer RJ: Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr 1998, 67:919–926.

    PubMed  CAS  Google Scholar 

  12. McCartney SA, Hallyburton EM, Patchett SE, Farthing MJG: Growth failure in inflammatory bowel disease [abstract]. Gastroenterology 1997, 112(suppl):A892.

    Google Scholar 

  13. Wilschanski M, Sherman P, Pencharz P, et al.: Supplementary enteral nutrition maintains remission in paediatric Crohn’s disease. Gut 1996, 38:543–548.

    PubMed  CAS  Google Scholar 

  14. Mahmud N, Weir DG: The urban diet and Crohn’s disease: is there a relationship? Eur J Gastroenterol Hepatol 2001, 13:93–95.

    Article  PubMed  CAS  Google Scholar 

  15. Bernstein CN, Papineau N, Zajaczkowski J, et al.: Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Am J Gastroenterol 2000, 95:677–683.

    Article  PubMed  CAS  Google Scholar 

  16. O’Morain C, McGuinness A: Crohn’s disease: enteral feeding. In Current Therapy in Gastroenterology and Liver Disease, edn 4. St Louis: Mosby; 1994:278–281. Includes practical guidelines for implementing elemental diet therapy in patients with Crohn’s disease.

    Google Scholar 

  17. Teahon K, Pearson M, Levi AJ, Bjarnason I: Practical aspects of enteral nutrition in the management of Crohn’s disease. JPEN J Parenter Enteral Nutr 1995, 19:365–368. Includes practical guidelines for implementing elemental diet therapy in patients with Crohn’s disease.

    PubMed  CAS  Google Scholar 

  18. Mansfield JC, Giaffer MH, Holdsworth CD: Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn’s disease. Gut 1995, 36:60–66.

    PubMed  CAS  Google Scholar 

  19. Lochs H, Steinhardt HJ, Klaus-Wentz B, et al.: Comparison of enteral nutrition and drug treatment in active Crohn’s disease. Results of the European Cooperative Crohn’s Disease Study. IV. Gastroenterology 1991, 101:881–888.

    PubMed  CAS  Google Scholar 

  20. Riordan AM, Hunter JO, Cowan RE, et al.: Treatment of active Crohn’s disease by exclusion diet: East Anglian multicentre controlled trial. Lancet 1993, 342:1131–1134.

    Article  PubMed  CAS  Google Scholar 

  21. Belluzzi A, Brignola C, Campieri M, et al.: Effects of new fish oil derivative on fatty acid phospholipidmembrane pattern in a group of Crohn’s disease patients. Dig Dis Sci 1994, 39:2589–2594.

    Article  PubMed  CAS  Google Scholar 

  22. Belluzzi A, Brignola C, Campieri M, et al.: Effect of an enteric-coated fish-oil preparation on relapses in Crohn’s disease. N Engl J Med 1996, 334:1557–1560.

    Article  PubMed  CAS  Google Scholar 

  23. Belluzzi A, Boschi S, Brignola C, et al.: Polyunsaturated fatty acids and inflammatory bowel disease. Am J Clin Nutr 2000, 71:339S-342S. This article reviews the role of fatty acids in the treatment of patients with Crohn’s disease.

    PubMed  CAS  Google Scholar 

  24. Akobeng AK, Miller V, Stanton J, et al.: Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn’s disease. J Pediatr Gastroenterol Nutr 2000, 30:78–84.

    Article  PubMed  CAS  Google Scholar 

  25. Segain JP, de La Bletiere DR, Bourreille A, et al.: Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn’s disease. Gut 2000, 47:397–403.

    Article  PubMed  CAS  Google Scholar 

  26. Perrin P, Pierre F, Patry Y, et al.: Only fibres promoting a stable butyrate producing colonic ecosystem decrease the rate of aberrant crypt foci in rats. Gut 2001, 48:53–61.

    Article  PubMed  CAS  Google Scholar 

  27. Shanahan F: Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm Bowel Dis 2000, 6:107–115. This article evaluates the role of probiotics in the treatment of patients with Crohn’s disease. The future application of probiotics may be in formulation of dietary treatment strategies.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Adelaide & Meath Hospital, Trinity College, Dublin 24, Ireland

    Maria O’Sullivan BSc, PhD & Colm O’Morain MD, MSc, DSc, FRCPI

Authors
  1. Maria O’Sullivan BSc, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Colm O’Morain MD, MSc, DSc, FRCPI
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

O’Sullivan, M., O’Morain, C. Nutritional treatments in inflammatory bowel disease. Curr Treat Options Gastro 4, 207–213 (2001). https://doi.org/10.1007/s11938-001-0033-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-001-0033-3

Keywords

Search

Navigation